What is InMed Pharmaceuticals Inc. Common Shares's Market Cap?

InMed Pharmaceuticals Inc. Common Shares's Market Cap is $4.4M, based on as-reported figures from SEC (XBRL) filings.

What is InMed Pharmaceuticals Inc. Common Shares's Price / Sales?

InMed Pharmaceuticals Inc. Common Shares's Price / Sales is 0.9×, based on as-reported figures from SEC (XBRL) filings.

What is InMed Pharmaceuticals Inc. Common Shares's Revenue (TTM)?

InMed Pharmaceuticals Inc. Common Shares's Revenue (TTM) is $4.9M, based on as-reported figures from SEC (XBRL) filings.

What is InMed Pharmaceuticals Inc. Common Shares's Net Income (TTM)?

InMed Pharmaceuticals Inc. Common Shares's Net Income (TTM) is -$8.5M, based on as-reported figures from SEC (XBRL) filings.

What is InMed Pharmaceuticals Inc. Common Shares's EBITDA?

InMed Pharmaceuticals Inc. Common Shares's EBITDA is -$8.3M, based on as-reported figures from SEC (XBRL) filings.

What is InMed Pharmaceuticals Inc. Common Shares's Diluted EPS (TTM)?

InMed Pharmaceuticals Inc. Common Shares's Diluted EPS (TTM) is -2.57, based on as-reported figures from SEC (XBRL) filings.

What is InMed Pharmaceuticals Inc. Common Shares's EBITDA Margin?

InMed Pharmaceuticals Inc. Common Shares's EBITDA Margin is -167.9%, based on as-reported figures from SEC (XBRL) filings.

InMed Pharmaceuticals Inc. Common Shares (INM) Financial Statements

InMed Pharmaceuticals Inc. Common Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SDV3N2

XNAS · usd

1.33▼ 0.05 (-3.62%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close1.38

Day's Range1.31 – 1.39

52-Week Range0.58 – 2.50

Volume63.0K

Avg Volume93.5K

Share Statistics

Shares Outstanding

Employees13

ExchangeXNAS

Listed2020-11-10

Share count as of May 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about InMed Pharmaceuticals Inc. Common Shares (INM)

What is InMed Pharmaceuticals Inc. Common Shares's Market Cap?: InMed Pharmaceuticals Inc. Common Shares's Market Cap is $4.4M, based on as-reported figures from SEC (XBRL) filings.
What is InMed Pharmaceuticals Inc. Common Shares's Price / Sales?: InMed Pharmaceuticals Inc. Common Shares's Price / Sales is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is InMed Pharmaceuticals Inc. Common Shares's Revenue (TTM)?: InMed Pharmaceuticals Inc. Common Shares's Revenue (TTM) is $4.9M, based on as-reported figures from SEC (XBRL) filings.
What is InMed Pharmaceuticals Inc. Common Shares's Net Income (TTM)?: InMed Pharmaceuticals Inc. Common Shares's Net Income (TTM) is -$8.5M, based on as-reported figures from SEC (XBRL) filings.
What is InMed Pharmaceuticals Inc. Common Shares's EBITDA?: InMed Pharmaceuticals Inc. Common Shares's EBITDA is -$8.3M, based on as-reported figures from SEC (XBRL) filings.
What is InMed Pharmaceuticals Inc. Common Shares's Diluted EPS (TTM)?: InMed Pharmaceuticals Inc. Common Shares's Diluted EPS (TTM) is -2.57, based on as-reported figures from SEC (XBRL) filings.
What is InMed Pharmaceuticals Inc. Common Shares's EBITDA Margin?: InMed Pharmaceuticals Inc. Common Shares's EBITDA Margin is -167.9%, based on as-reported figures from SEC (XBRL) filings.